nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—MYT1—testis—malignant mesothelioma	0.0194	0.0194	CbGeAlD
Dasatinib—BMX—epithelium—malignant mesothelioma	0.0182	0.0182	CbGeAlD
Dasatinib—TEC—testis—malignant mesothelioma	0.0165	0.0165	CbGeAlD
Dasatinib—STAT5B—epithelium—malignant mesothelioma	0.0161	0.0161	CbGeAlD
Dasatinib—EPHB1—testis—malignant mesothelioma	0.013	0.013	CbGeAlD
Dasatinib—BMPR1B—epithelium—malignant mesothelioma	0.0129	0.0129	CbGeAlD
Dasatinib—BTK—decidua—malignant mesothelioma	0.0121	0.0121	CbGeAlD
Dasatinib—TNK2—decidua—malignant mesothelioma	0.0119	0.0119	CbGeAlD
Dasatinib—BMX—lung—malignant mesothelioma	0.0115	0.0115	CbGeAlD
Dasatinib—TESK1—decidua—malignant mesothelioma	0.0112	0.0112	CbGeAlD
Dasatinib—FRK—testis—malignant mesothelioma	0.0112	0.0112	CbGeAlD
Dasatinib—PKMYT1—testis—malignant mesothelioma	0.0112	0.0112	CbGeAlD
Dasatinib—STK36—decidua—malignant mesothelioma	0.0111	0.0111	CbGeAlD
Dasatinib—SRMS—lung—malignant mesothelioma	0.011	0.011	CbGeAlD
Dasatinib—TXK—lung—malignant mesothelioma	0.0109	0.0109	CbGeAlD
Dasatinib—PTK6—lung—malignant mesothelioma	0.0108	0.0108	CbGeAlD
Dasatinib—LIMK2—decidua—malignant mesothelioma	0.0107	0.0107	CbGeAlD
Dasatinib—TXK—testis—malignant mesothelioma	0.0103	0.0103	CbGeAlD
Dasatinib—CSK—decidua—malignant mesothelioma	0.0103	0.0103	CbGeAlD
Dasatinib—STAT5B—lung—malignant mesothelioma	0.0102	0.0102	CbGeAlD
Dasatinib—EPHA8—testis—malignant mesothelioma	0.0102	0.0102	CbGeAlD
Dasatinib—HCK—decidua—malignant mesothelioma	0.0102	0.0102	CbGeAlD
Dasatinib—RIPK2—epithelium—malignant mesothelioma	0.0101	0.0101	CbGeAlD
Dasatinib—ERBB3—epithelium—malignant mesothelioma	0.00967	0.00967	CbGeAlD
Dasatinib—STAT5B—testis—malignant mesothelioma	0.00964	0.00964	CbGeAlD
Dasatinib—RIPK2—decidua—malignant mesothelioma	0.00955	0.00955	CbGeAlD
Dasatinib—EPHA3—lung—malignant mesothelioma	0.00945	0.00945	CbGeAlD
Dasatinib—SIK1—decidua—malignant mesothelioma	0.00932	0.00932	CbGeAlD
Dasatinib—SIK3—lung—malignant mesothelioma	0.00919	0.00919	CbGeAlD
Dasatinib—MAPK14—epithelium—malignant mesothelioma	0.00901	0.00901	CbGeAlD
Dasatinib—EPHA3—testis—malignant mesothelioma	0.00891	0.00891	CbGeAlD
Dasatinib—SIK3—testis—malignant mesothelioma	0.00867	0.00867	CbGeAlD
Dasatinib—ZAK—lung—malignant mesothelioma	0.00854	0.00854	CbGeAlD
Dasatinib—EPHB4—epithelium—malignant mesothelioma	0.00854	0.00854	CbGeAlD
Dasatinib—MAPK14—decidua—malignant mesothelioma	0.00851	0.00851	CbGeAlD
Dasatinib—JAK2—epithelium—malignant mesothelioma	0.00848	0.00848	CbGeAlD
Dasatinib—LCK—decidua—malignant mesothelioma	0.00848	0.00848	CbGeAlD
Dasatinib—FGR—decidua—malignant mesothelioma	0.00848	0.00848	CbGeAlD
Dasatinib—EPHA2—epithelium—malignant mesothelioma	0.00838	0.00838	CbGeAlD
Dasatinib—MAP3K19—lung—malignant mesothelioma	0.00819	0.00819	CbGeAlD
Dasatinib—BMPR1B—lung—malignant mesothelioma	0.00819	0.00819	CbGeAlD
Dasatinib—BTK—lung—malignant mesothelioma	0.00815	0.00815	CbGeAlD
Dasatinib—EPHB4—decidua—malignant mesothelioma	0.00807	0.00807	CbGeAlD
Dasatinib—ZAK—testis—malignant mesothelioma	0.00806	0.00806	CbGeAlD
Dasatinib—TNK2—lung—malignant mesothelioma	0.00803	0.00803	CbGeAlD
Dasatinib—JAK2—decidua—malignant mesothelioma	0.00801	0.00801	CbGeAlD
Dasatinib—EPHA2—decidua—malignant mesothelioma	0.00791	0.00791	CbGeAlD
Dasatinib—FYN—decidua—malignant mesothelioma	0.0079	0.0079	CbGeAlD
Dasatinib—MAP3K19—testis—malignant mesothelioma	0.00773	0.00773	CbGeAlD
Dasatinib—BMPR1B—testis—malignant mesothelioma	0.00773	0.00773	CbGeAlD
Dasatinib—MAP3K3—decidua—malignant mesothelioma	0.00772	0.00772	CbGeAlD
Dasatinib—MAP4K5—decidua—malignant mesothelioma	0.00772	0.00772	CbGeAlD
Dasatinib—BTK—testis—malignant mesothelioma	0.00769	0.00769	CbGeAlD
Dasatinib—TNK2—testis—malignant mesothelioma	0.00758	0.00758	CbGeAlD
Dasatinib—TESK1—lung—malignant mesothelioma	0.00755	0.00755	CbGeAlD
Dasatinib—STK36—lung—malignant mesothelioma	0.00743	0.00743	CbGeAlD
Dasatinib—EPHB3—lung—malignant mesothelioma	0.00743	0.00743	CbGeAlD
Dasatinib—EPHB6—decidua—malignant mesothelioma	0.00738	0.00738	CbGeAlD
Dasatinib—SRC—epithelium—malignant mesothelioma	0.00726	0.00726	CbGeAlD
Dasatinib—LIMK2—lung—malignant mesothelioma	0.00719	0.00719	CbGeAlD
Dasatinib—YES1—decidua—malignant mesothelioma	0.00713	0.00713	CbGeAlD
Dasatinib—TESK1—testis—malignant mesothelioma	0.00713	0.00713	CbGeAlD
Dasatinib—STK36—testis—malignant mesothelioma	0.00701	0.00701	CbGeAlD
Dasatinib—EPHB3—testis—malignant mesothelioma	0.00701	0.00701	CbGeAlD
Dasatinib—PDGFRA—decidua—malignant mesothelioma	0.00699	0.00699	CbGeAlD
Dasatinib—STK35—lung—malignant mesothelioma	0.00697	0.00697	CbGeAlD
Dasatinib—CSK—lung—malignant mesothelioma	0.00692	0.00692	CbGeAlD
Dasatinib—SRC—decidua—malignant mesothelioma	0.00686	0.00686	CbGeAlD
Dasatinib—HCK—lung—malignant mesothelioma	0.00683	0.00683	CbGeAlD
Dasatinib—ABL2—lung—malignant mesothelioma	0.00679	0.00679	CbGeAlD
Dasatinib—LIMK2—testis—malignant mesothelioma	0.00678	0.00678	CbGeAlD
Dasatinib—STK35—testis—malignant mesothelioma	0.00657	0.00657	CbGeAlD
Dasatinib—CSK—testis—malignant mesothelioma	0.00653	0.00653	CbGeAlD
Dasatinib—HCK—testis—malignant mesothelioma	0.00645	0.00645	CbGeAlD
Dasatinib—RIPK2—lung—malignant mesothelioma	0.00642	0.00642	CbGeAlD
Dasatinib—ABL2—testis—malignant mesothelioma	0.0064	0.0064	CbGeAlD
Dasatinib—MAP2K5—decidua—malignant mesothelioma	0.00631	0.00631	CbGeAlD
Dasatinib—SIK1—lung—malignant mesothelioma	0.00627	0.00627	CbGeAlD
Dasatinib—EPHA4—lung—malignant mesothelioma	0.00621	0.00621	CbGeAlD
Dasatinib—CSF1R—decidua—malignant mesothelioma	0.00616	0.00616	CbGeAlD
Dasatinib—ERBB3—lung—malignant mesothelioma	0.00615	0.00615	CbGeAlD
Dasatinib—MAP3K2—lung—malignant mesothelioma	0.00609	0.00609	CbGeAlD
Dasatinib—RIPK2—testis—malignant mesothelioma	0.00606	0.00606	CbGeAlD
Dasatinib—KIT—epithelium—malignant mesothelioma	0.00592	0.00592	CbGeAlD
Dasatinib—SIK1—testis—malignant mesothelioma	0.00592	0.00592	CbGeAlD
Dasatinib—EPHA4—testis—malignant mesothelioma	0.00586	0.00586	CbGeAlD
Dasatinib—ERBB3—testis—malignant mesothelioma	0.0058	0.0058	CbGeAlD
Dasatinib—PDGFRB—epithelium—malignant mesothelioma	0.00578	0.00578	CbGeAlD
Dasatinib—MAP3K2—testis—malignant mesothelioma	0.00574	0.00574	CbGeAlD
Dasatinib—MAPK14—lung—malignant mesothelioma	0.00572	0.00572	CbGeAlD
Dasatinib—FGR—lung—malignant mesothelioma	0.0057	0.0057	CbGeAlD
Dasatinib—LCK—lung—malignant mesothelioma	0.0057	0.0057	CbGeAlD
Dasatinib—KIT—decidua—malignant mesothelioma	0.00559	0.00559	CbGeAlD
Dasatinib—FMO3—lung—malignant mesothelioma	0.00551	0.00551	CbGeAlD
Dasatinib—PDGFRB—decidua—malignant mesothelioma	0.00546	0.00546	CbGeAlD
Dasatinib—EPHB4—lung—malignant mesothelioma	0.00543	0.00543	CbGeAlD
Dasatinib—MAPK14—testis—malignant mesothelioma	0.0054	0.0054	CbGeAlD
Dasatinib—JAK2—lung—malignant mesothelioma	0.00539	0.00539	CbGeAlD
Dasatinib—FGR—testis—malignant mesothelioma	0.00538	0.00538	CbGeAlD
Dasatinib—LCK—testis—malignant mesothelioma	0.00538	0.00538	CbGeAlD
Dasatinib—EPHA2—lung—malignant mesothelioma	0.00532	0.00532	CbGeAlD
Dasatinib—FYN—lung—malignant mesothelioma	0.00531	0.00531	CbGeAlD
Dasatinib—FMO3—testis—malignant mesothelioma	0.0052	0.0052	CbGeAlD
Dasatinib—MAP3K3—lung—malignant mesothelioma	0.00519	0.00519	CbGeAlD
Dasatinib—MAP4K5—lung—malignant mesothelioma	0.00519	0.00519	CbGeAlD
Dasatinib—EPHB4—testis—malignant mesothelioma	0.00512	0.00512	CbGeAlD
Dasatinib—JAK2—testis—malignant mesothelioma	0.00508	0.00508	CbGeAlD
Dasatinib—EPHA2—testis—malignant mesothelioma	0.00502	0.00502	CbGeAlD
Dasatinib—FYN—testis—malignant mesothelioma	0.00501	0.00501	CbGeAlD
Dasatinib—EPHB6—lung—malignant mesothelioma	0.00496	0.00496	CbGeAlD
Dasatinib—MAP4K5—testis—malignant mesothelioma	0.0049	0.0049	CbGeAlD
Dasatinib—MAP3K3—testis—malignant mesothelioma	0.0049	0.0049	CbGeAlD
Dasatinib—ABL1—decidua—malignant mesothelioma	0.00487	0.00487	CbGeAlD
Dasatinib—YES1—lung—malignant mesothelioma	0.0048	0.0048	CbGeAlD
Dasatinib—PDGFRA—lung—malignant mesothelioma	0.0047	0.0047	CbGeAlD
Dasatinib—EPHB6—testis—malignant mesothelioma	0.00468	0.00468	CbGeAlD
Dasatinib—SRC—lung—malignant mesothelioma	0.00461	0.00461	CbGeAlD
Dasatinib—YES1—testis—malignant mesothelioma	0.00453	0.00453	CbGeAlD
Dasatinib—PDGFRA—testis—malignant mesothelioma	0.00444	0.00444	CbGeAlD
Dasatinib—SRC—testis—malignant mesothelioma	0.00435	0.00435	CbGeAlD
Dasatinib—MAP2K5—lung—malignant mesothelioma	0.00424	0.00424	CbGeAlD
Dasatinib—CSF1R—lung—malignant mesothelioma	0.00414	0.00414	CbGeAlD
Dasatinib—CYP1B1—decidua—malignant mesothelioma	0.00412	0.00412	CbGeAlD
Dasatinib—MAP2K5—testis—malignant mesothelioma	0.004	0.004	CbGeAlD
Dasatinib—CSF1R—testis—malignant mesothelioma	0.00391	0.00391	CbGeAlD
Dasatinib—KIT—lung—malignant mesothelioma	0.00376	0.00376	CbGeAlD
Dasatinib—PDGFRB—lung—malignant mesothelioma	0.00367	0.00367	CbGeAlD
Dasatinib—KIT—testis—malignant mesothelioma	0.00355	0.00355	CbGeAlD
Dasatinib—PDGFRB—testis—malignant mesothelioma	0.00347	0.00347	CbGeAlD
Dasatinib—ABL1—lung—malignant mesothelioma	0.00327	0.00327	CbGeAlD
Dasatinib—ABL1—testis—malignant mesothelioma	0.00309	0.00309	CbGeAlD
Dasatinib—CYP1A1—epithelium—malignant mesothelioma	0.00309	0.00309	CbGeAlD
Dasatinib—ABCG2—decidua—malignant mesothelioma	0.00307	0.00307	CbGeAlD
Dasatinib—CYP1B1—lung—malignant mesothelioma	0.00277	0.00277	CbGeAlD
Dasatinib—CYP1B1—testis—malignant mesothelioma	0.00262	0.00262	CbGeAlD
Dasatinib—ABCG2—lung—malignant mesothelioma	0.00206	0.00206	CbGeAlD
Dasatinib—CYP1A2—lung—malignant mesothelioma	0.00199	0.00199	CbGeAlD
Dasatinib—CYP1A1—lung—malignant mesothelioma	0.00196	0.00196	CbGeAlD
Dasatinib—ABCG2—testis—malignant mesothelioma	0.00195	0.00195	CbGeAlD
Dasatinib—CYP3A5—lung—malignant mesothelioma	0.00192	0.00192	CbGeAlD
Dasatinib—ABCB1—epithelium—malignant mesothelioma	0.0016	0.0016	CbGeAlD
Dasatinib—ABCB1—decidua—malignant mesothelioma	0.00151	0.00151	CbGeAlD
Dasatinib—ABCB1—lung—malignant mesothelioma	0.00102	0.00102	CbGeAlD
Dasatinib—ABCB1—testis—malignant mesothelioma	0.000961	0.000961	CbGeAlD
